Literature DB >> 17227728

Cytokine production from peripheral blood mononuclear cells in patients with ankylosing spondylitis and their first-degree relatives.

Chung-Tei Chou1, An-Ping Huo, Hsiao-Ning Chang, Chang-Youh Tsai, Wei-Sheng Chen, Hon-Pin Wang.   

Abstract

BACKGROUND: To understand the cytokine levels in different disease activities of patients with ankylosing spondylitis (AS), we measured proinflammatory and antiinflammatory cytokine production from peripheral blood mononuclear cells (PBMC) in patients with AS and their first-degree relatives (FDR).
METHODS: PBMC were obtained from 26 patients with AS and 24 FDR and then stimulated with PHA for 72 h. In the supernatants, the following three cytokines, tumor necrosis factor-alpha (TNF-alpha), interleukin 1beta (IL-1beta), and IL-10, were measured by ELISA. Disease activity in AS patients was divided into high disease activity (Group 1) and low disease activity (Group 2), based on the Bath AS Disease Activity Index (BASDAI > or =4 or <4). Healthy FDR of AS patients (Group 3) and healthy subjects (Group 4) were used as a control group.
RESULTS: TNF-alpha production from PBMC was significantly increased in Group 1 patients compared to Group 2 patients (1371 +/- 1008 pg/mL vs. 355 +/- 89 pg/mL, p <0.05) or FDR (1371 +/- 1008 pg/mL vs. 552 +/- 89 pg/mL, p <0.05) or healthy subjects (1371 +/- 1008 pg/mL vs. 436 +/- 114 pg/mL, p <0.01). IL-1beta also showed a similarly significant difference between the two groups (Group 1 vs. Group 2, Group 1 vs. Group 4) (p <0.05). In contrast, IL-10 was significantly decreased in Group 1 when compared to Group 2 (126 +/- 64 pg/mL vs. 272 +/- 150 pg/mL, p <0.05).
CONCLUSIONS: Patients with high BASDAI had increased production of TNF-alpha and IL-1beta compared to those with low BASDAI or healthy FDR, suggesting that proinflammatory cytokines may play an important role during active inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17227728     DOI: 10.1016/j.arcmed.2006.09.008

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  10 in total

Review 1.  Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.

Authors:  M L Stoll
Journal:  Clin Exp Rheumatol       Date:  2011-04-19       Impact factor: 4.473

2.  IL1R1 polymorphisms are associated with ankylosing spondylitis in the Han Chinese population: a case-control study.

Authors:  Yuyan Na; Rui Bai; Yizhong Ren; Zhenqun Zhao; Lingyue Kong; Ruifeng Li; Changxu Han; Haisheng Jia
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

3.  Inverse correlation of programmed death 1 (PD-1) expression in T cells to the spinal radiologic changes in Taiwanese patients with ankylosing spondylitis.

Authors:  Ming-Han Chen; Wei-Sheng Chen; Hui-Ting Lee; Chang-Youh Tsai; Chung-Tei Chou
Journal:  Clin Rheumatol       Date:  2011-03-10       Impact factor: 2.980

4.  T-cell responses to versican in ankylosing spondylitis.

Authors:  Tae-Jong Kim; Tae-Hwan Kim; Hyun-Joo Lee; Bitnara Lee; A Robin Poole; Robert D Inman
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

5.  Protective effect of naringin against ankylosing spondylitis via ossification, inflammation and oxidative stress in mice.

Authors:  Kang Liu; Lianguo Wu; Xiaolin Shi; Fengqing Wu
Journal:  Exp Ther Med       Date:  2016-05-31       Impact factor: 2.447

6.  The effect of TNF-alpha blockers on psychometric measures in ankylosing spondylitis patients: a preliminary observation.

Authors:  Ozden Arısoy; Cemal Bes; Cigdem Cifci; Mustafa Sercan; Mehmet Soy
Journal:  Rheumatol Int       Date:  2013-01-20       Impact factor: 2.631

7.  The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis.

Authors:  Ingo H Tarner; Ulf Müller-Ladner; Christine Uhlemann; Uwe Lange
Journal:  Clin Rheumatol       Date:  2008-12-17       Impact factor: 2.980

8.  The Protective Effect of Chrysanthemum indicum Extract against Ankylosing Spondylitis in Mouse Models.

Authors:  Mei Dong; Dongsheng Yu; Veeramuthu Duraipandiyan; Naif Abdullah Al-Dhabi
Journal:  Biomed Res Int       Date:  2017-02-02       Impact factor: 3.411

9.  Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis.

Authors:  Matheus Braga; Fernanda Formaggi Lara-Armi; Janisleya Silva Ferreira Neves; Marco Antônio Rocha-Loures; Mariana de Souza Terron-Monich; Larissa Danielle Bahls-Pinto; Quirino Alves de Lima Neto; Joana Maira Valentini Zacarias; Ana Maria Sell; Jeane Eliete Laguila Visentainer
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

10.  Ankylosing spondylitis: from cells to genes.

Authors:  José Francisco Zambrano-Zaragoza; Juan Manuel Agraz-Cibrian; Christian González-Reyes; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2013-07-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.